Last reviewed · How we verify

Professional Disposables International, Inc. — Portfolio Competitive Intelligence Brief

Professional Disposables International, Inc. pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Prevantics Maxi Swabstick Prevantics Maxi Swabstick marketed Topical antiseptic Infection Prevention
Isopropyl alcohol & Chlorhexidine Gluconate Antiseptic Isopropyl alcohol & Chlorhexidine Gluconate Antiseptic phase 3 Topical antiseptic combination Infection Prevention / Dermatology
Prevantics 3.15 % / 70 % Swabstick Prevantics 3.15 % / 70 % Swabstick phase 3 Topical antiseptic Infection Prevention / Surgical Site Prophylaxis

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Zurex Pharma, Inc. · 2 shared drug classes
  2. Case Western Reserve University · 1 shared drug class
  3. Central DuPage Hospital · 1 shared drug class
  4. Hospital Regional de Alta Especialidad del Bajio · 1 shared drug class
  5. Instituto de Investigacion Sanitaria La Fe · 1 shared drug class
  6. C. R. Bard · 1 shared drug class
  7. Poitiers University Hospital · 1 shared drug class
  8. Solventum US LLC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Professional Disposables International, Inc.:

Cite this brief

Drug Landscape (2026). Professional Disposables International, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/professional-disposables-international-inc. Accessed 2026-05-18.

Related